Insider Shareholders with Direct Ownership of Magenta Therapeutics, Inc. (MGTA)
This section provides a comprehensive overview of the insiders with direct ownership of Magenta Therapeutics, Inc. (MGTA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Magenta Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Atlas Venture Fund X, L.P.
> 10% Shareholder |
0 | 968,726 | 3,148,399 $0 | 1 |
Feb 11, 2021
Reduced 23.53%
|
|
Third Rock Ventures Iv, L.P.
> 10% Shareholder |
7,911,455 | 4,950,000 | 3,058,204 $0 | 4 |
Feb 08, 2023
Reduced 32.91%
|
|
Jason Gardner
Director |
56,000 | 14,340 | 292,872 $0 | 4 |
Nov 30, 2022
Added 1.01%
|
|
Kristen Stants
Chief People Officer |
26,000 | 5,736 | 20,264 $0 | 4 |
Nov 30, 2022
Added 12.9%
|
|
Thomas W. Beetham
Officer |
26,000 | 6,103 | 19,897 $0 | 4 |
Nov 30, 2022
Added 13.1%
|
|
Caren Deardorf
Chief Commercial Officer |
26,000 | 6,238 | 19,762 $0 | 4 |
Nov 30, 2022
Added 13.18%
|
|
Stephen F. Mahoney
Officer |
23,000 | 5,736 | 17,264 $0 | 3 |
Nov 30, 2022
Added 14.8%
|
|
David Wayne Nichols
Chief Technical Officer |
20,000 | 5,694 | 14,306 $0 | 2 |
Sep 16, 2021
Reduced 28.47%
|
|
Lisa Olson
Officer |
20,000 | 5,736 | 14,264 $0 | 2 |
Sep 16, 2021
Reduced 28.68%
|
|
Alexis Borisy
Director |
4,100 | 0 | 4,100 $0 | 1 |
Aug 26, 2021
Added 50.0%
|
|
Simrat Randhawa
CHIEF MEDICAL OFFICER |
4,000 | 0 | 4,000 $0 | 2 |
Sep 22, 2023
Added 33.33%
|